does tirzepatide improve mood Can (a dual GIP and GLP-1 receptor agonist) cause swings in patients with type 2 diabetes, particularly those with a history of depression or anxiety? Did you know the benefits

Ready to Start a Physician-Led Medical Weight Loss Program Near Phoenix

In clinical trials, WeGovy, Mounjaro and Ozempic were shown to be effective but had many potential side effects, one side effect, which was demonstrated to affect between 3 and 6% of patients in trials, was reported hair loss

Competing interests Massy M reports no competing interests

The S&P 500's 3 Best-Performing Stocks So Far in 2026 Last quarter, the company submitted its drug orforglipron, a new GLP-1 agonist, for obesity treatment in the United States and more than three dozen additional countries, with an expected domestic launch by mid-2026

Most patients find the experience relaxing and easy to tolerate

Acetyl-CoA serves as a primary driver for histone acetylation, a process facilitated by lactate dehydrogenase A (LDHA)